DUBAI, UAE - October 24, 2025 (NEWMEDIAWIRE) - BMP AI Technologies Inc. (OTC: BMPA) (the "Company"), today issued a statement regarding the Caveat Emptor designation applied by OTC Markets Group on October 22, 2025.
The Company has been in active communication with OTC Markets to understand the basis for the designation. OTC Markets has indicated that the designation relates to its review of the Company’s publicly available financial information and the recent market activity in its securities. OTC Markets has provided the Company with a detailed list of supplemental information that it has requested from the Company. The Company intends to furnish all such information promptly and expects to complete its response within the week.
The Company reiterates that it has not authorized or engaged any third parties to conduct promotional, marketing, or investor relations campaigns on its behalf. The Company remains fully committed to transparency, regulatory compliance, and accurate disclosure, and is cooperating fully with OTC Markets to expedite the removal of the caveat emptor designation.
OTC Markets has informed the Company that such designations are generally maintained for a 30 day period; however, under the circumstances, the Company and its legal counsel will be requesting that the 30-day policy be waived and that the designation be removed upon verification of the requested supplemental information.
"We are aware of the designation and are taking this matter very seriously," said a spokesperson for BMPA. "Our team is fully committed to cooperating with OTC Markets and ensuring our compliance. We will continue to keep our shareholders informed as we work through this process."
The Company confirms that its operations and SEC filings remain current. Additional information about BMP AI Technologies Inc. is available at www.bmpaitech.com or by visiting www.sec.gov.
About BMP AI Technologies Inc.
BMP AI Technologies Inc. (OTC: BMPA) is a next-generation artificial intelligence and blockchain development company specializing in enterprise automation, data integrity, and decentralized business solutions. Through its technology alliances, BMP AI delivers transformative products such as HeartEase (AI-powered health diagnostics), BMP AI (enterprise chatbots), and proprietary blockchain platforms designed for secure information distribution and internal enterprise payments.
Legal Disclaimer and Forward-Looking Statements
This press release contains forward-looking statements as defined under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, estimates, projections, and assumptions made by BMP AI Technologies Inc. (the "Company" or "BMPA"). Forward-looking statements may include words such as "aims," "anticipates," "believes," "plans," "expects," "intends," "will," "may," "could," "should," and similar expressions.
These statements relate to, among other things, the expected performance and capabilities of the BMP AI platform; the Company's ability to successfully complete product development, enter commercial deployment, or scale its technology; future revenues and market expansion; and general strategic direction. All such statements are inherently uncertain and involve a number of risks that could cause actual results to differ materially from those expressed or implied in any forward-looking statement.
BMP AI Technologies Inc. is a fully reporting company with the U.S. Securities and Exchange Commission (SEC) and files annual and quarterly reports, current reports, and other required disclosures. All public filings and disclosures may be reviewed at the SEC's EDGAR database at www.sec.gov. The Company trades on the OTC Markets under the ticker symbol BMPA.
This press release is not, and should not be construed as, an offer to sell or a solicitation of an offer to buy any securities of BMP AI Technologies Inc. in the United States or in any other jurisdiction. Offers and sales of securities, if any, will be made only pursuant to an effective registration statement or valid exemption under the U.S. Securities Act of 1933, as amended.
Investing in securities traded on the OTC Markets involves significant risk, including potential loss of principal, low liquidity, high volatility, and limited publicly available information. Investors are strongly advised to conduct their own due diligence, consult a qualified investment advisor, and carefully review all SEC filings prior to making any investment decision.
Media Contact:
BMP AI Technologies Inc.
Investors Relations
ir@bmpaitech.com
(727) 314-3717
View the original release on www.newmediawire.com
